Cancer Proteomics: The State of the Art

Now that the human genome has been determined, the field of proteomics is ramping up to tackle the vast protein networks that both control and are controlled by the information encoded by the genome. The study of proteomics should yield an unparalleled understanding of cancer as well as an invaluable new target for therapeutic intervention and markers for early detection. This rapidly expanding field attempts to track the protein interactions responsible for all cellular processes. By careful analysis of these systems, a detailed understanding of the molecular causes and consequences of cancer should emerge. A brief overview of some of the cutting edge technologies employed by this rapidly expanding field is given, along with specific examples of how these technologies are employed. Soon cellular protein networks will be understood at a level that will permit a totally new paradigm of diagnosis and will allow therapy tailored to individual patients and situations.

[1]  B. Austen,et al.  The use of Seldi ProteinChip™ Arrays to monitor production of Alzheimer's β‐amyloid in transfected cells , 2000 .

[2]  V. Soldatenkov,et al.  Identification of keratins 18, 19 and heat-shock protein 90 beta as candidate substrates of proteolysis during ionizing radiation-induced apoptosis of estrogen-receptor negative breast tumor cells. , 1998, International journal of oncology.

[3]  F. Lottspeich,et al.  Proteomics--a new way for drug target discovery. , 1998, Arzneimittel-Forschung.

[4]  H. Kato,et al.  Relationship between TA01 and TA02 polypeptides associated with lung adenocarcinoma and histocytological features. , 1997, British Journal of Cancer.

[5]  D. Mccormick.  Sequence the Human Genome , 1986, Bio/Technology.

[6]  J. Celis,et al.  Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. , 1996, Cancer research.

[7]  D. Haussler,et al.  A physical map of the human genome , 2001, Nature.

[8]  K. Resing,et al.  Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry. , 2000, Molecular cell.

[9]  E. Petricoin,et al.  An approach to proteomic analysis of human tumors , 2000, Molecular carcinogenesis.

[10]  C. Paweletz,et al.  Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  M J O'Hare,et al.  Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Görg,et al.  The current state of two‐dimensional electrophoresis with immobilized pH gradients , 2000, Electrophoresis.

[13]  E. Petricoin,et al.  Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip , 2000 .

[14]  E. Zuckerkandl,et al.  Quantitative protein changes in metastatic versus primary epithelial ovarian carcinoma. , 1991, Gynecologic oncology.

[15]  D. Hochstrasser,et al.  Two-dimensional electrophoretic study of normal colon mucosa and colorectal cancer. , 1994, Applied and theoretical electrophoresis : the official journal of the International Electrophoresis Society.

[16]  B. Schwikowski,et al.  A network of protein–protein interactions in yeast , 2000, Nature Biotechnology.

[17]  E. Petricoin,et al.  Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines , 2000, Electrophoresis.

[18]  M. Gross,et al.  Fourier transform mass spectrometry. , 1984, Science.

[19]  J. Jukema,et al.  Tailored Therapy to Fit Individual Profiles: Genetics and Coronary Artery Disease , 2000, Annals of the New York Academy of Sciences.

[20]  S. Mohan,et al.  Differential protein profile in the ear-punched tissue of regeneration and non-regeneration strains of mice: a novel approach to explore the candidate genes for soft-tissue regeneration. , 2000, Biochimica et biophysica acta.

[21]  E. Petricoin,et al.  Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front , 2001, Oncogene.

[22]  Robert F. Bonner,et al.  Laser Capture Microdissection: Molecular Analysis of Tissue , 1997, Science.

[23]  J. Celis,et al.  Bladder squamous cell carcinoma biomarkers derived from proteomics , 2000, Electrophoresis.

[24]  J. Gordon,et al.  Molecular analysis of commensal host-microbial relationships in the intestine. , 2001, Science.

[25]  J R Yates,et al.  Protein sequencing by tandem mass spectrometry. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[26]  D. Hochstrasser,et al.  Renal cell carcinoma and normal kidney protein expression , 1997, Electrophoresis.

[27]  P. Chaurand,et al.  Peptide and protein identification by matrix-assisted laser desorption ionization (MALDI) and MALDI-post-source decay time-of-flight mass spectrometry , 1999, Journal of the American Society for Mass Spectrometry.

[28]  D. Pappin,et al.  The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis — Preliminary findings , 1999, Electrophoresis.

[29]  S. Nock,et al.  Proteomics: Die post‐genomische Revolution , 2000 .

[30]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[31]  R. Kuick,et al.  Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas , 1999, British Journal of Cancer.

[32]  J. Kononen,et al.  Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.

[33]  P R Taylor,et al.  Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. , 2000, Cancer research.

[34]  Katherine B. Williams,et al.  A two‐dimensional electrophoresis database of human breast epithelial cell proteins , 1997, Electrophoresis.

[35]  R. Srinivasan,et al.  Ablation of polymers and biological tissue by ultraviolet lasers. , 1986, Science.

[36]  H. Jörnvall,et al.  Analysis of polypeptide expression in benign and malignant human breast lesions , 1997, Electrophoresis.

[37]  T. Hirano,et al.  Characterization of gene expression in clinical lung cancer materials by two‐dimensional polyacrylamide gel electrophoresis , 1994, Electrophoresis.

[38]  Emanuel Petricoin,et al.  Molecular profiling of human cancer , 2000, Nature Reviews Genetics.

[39]  R. Schwartz,et al.  In search of perverse polymorphisms. , 1998, The New England journal of medicine.

[40]  L. Liotta,et al.  Laser Capture Microdissection , 1996, Science.

[41]  G. Auer,et al.  Cancer proteomics: From identification of novel markers to creation of artifical learning models for tumor classification , 2000, Electrophoresis.

[42]  R. Moritz,et al.  A two‐dimensional gel database of human colon carcinoma proteins , 1997, Electrophoresis.

[43]  J. Laine,et al.  The protooncogene TCL1 is an Akt kinase coactivator. , 2000, Molecular cell.

[44]  Y. Katagata,et al.  Keratin expression and its significance in five cultured melanoma cell lines derived from primary, recurrent and metastasized melanomas , 1997, FEBS letters.

[45]  The International HapMap Consortium,et al.  A physical map of the human genome , 2001 .